recently moved our administrative headquarters and research labs to Freeport, Grand Bahama Island in The Bahamas, to be able to take advantage of the many benefits available to us there in our search for R&D and treatment of diseases, disorders and ailments. Esperanza has a broad base of ongoing interests encompassing research and development relating to the treatment and possible cures for many forms of disease.

We are extremely proud and honored to have on our staff scientists from diverse disciplines, expertise and experiences. A very solid foundation has been established upon which exciting research and development is currently being conducted. Such talents have created a dedicated entity with a single focus - that focus being: the research of novel approaches to the treatment of disease worldwide.

Our research technology has been in development for many years. We are now seeking to enter into clinical studies and to submit to drug regulatory approval agencies.

Esperanza's current focus is divided into two research projects: one on a neurological disorder focusing on Multiple Sclerosis (MS) and other neurological diseases, and the other on a viral disorder. MS is a disease, which affects as many as 3 million people. We have had excellent results to date on our MS project ( for more information on our success in treating MS and view actual patient testimonials please click here ). In virology, research will concentrate on inhibiting HIV / AIDS infection. In both cases, our research will lead to a novel, more tolerable and cost effective therapeutic solution!